Robinson, G.I.; Gerasymchuk, M.; Zanikov, T.; Gojani, E.G.; Asghari, S.; Groves, A.; Haselhorst, L.; Nandakumar, S.; Stahl, C.; Cruz, C.;
et al. LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice. Pharmaceuticals 2025, 18, 451.
https://doi.org/10.3390/ph18040451
AMA Style
Robinson GI, Gerasymchuk M, Zanikov T, Gojani EG, Asghari S, Groves A, Haselhorst L, Nandakumar S, Stahl C, Cruz C,
et al. LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice. Pharmaceuticals. 2025; 18(4):451.
https://doi.org/10.3390/ph18040451
Chicago/Turabian Style
Robinson, Gregory Ian, Marta Gerasymchuk, Timur Zanikov, Esmaeel Ghasemi Gojani, Shima Asghari, Alyssa Groves, Lucie Haselhorst, Sanjana Nandakumar, Cora Stahl, Ceejay Cruz,
and et al. 2025. "LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice" Pharmaceuticals 18, no. 4: 451.
https://doi.org/10.3390/ph18040451
APA Style
Robinson, G. I., Gerasymchuk, M., Zanikov, T., Gojani, E. G., Asghari, S., Groves, A., Haselhorst, L., Nandakumar, S., Stahl, C., Cruz, C., Cameron, M., Zahoruiko, Y., Li, D., Rodriguez-Juarez, R., Snelling, A., Hudson, D., Fiselier, A., Kovalchuk, O., & Kovalchuk, I.
(2025). LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice. Pharmaceuticals, 18(4), 451.
https://doi.org/10.3390/ph18040451
